CIT Group Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:CIT Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1449
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:109
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

CIT Group Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s CIT Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by CIT Group Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes CIT Group Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by CIT Group Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on CIT Group Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by CIT Group Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for CIT Group Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about CIT Group Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 23
Corporate Venturing – Overview 23
Corporate Venturing – Deal reports 24
PARTNERSHIP 26
Partnership – Overview 26
Partnership – Deal reports 27
CAPITAL RAISING 34
Capital Raising – Overview 34
Capital Raising – Deal reports 35
DIVESTMENTS 46
Divestments – Overview 46
Divestments – Deal reports 47
PRIVATE EQUITY & OWNERSHIP 97
Private Equity and Ownership – Deal reports 97
APPENDIX 99
Contact Us 99
About MarketLine Financial Deals Database 99
Deal Definition and Methodology 101
About MarketLine 108

List of Tables
Table 1: CIT Group Inc M&A volume and value trend (2014-YTD2018)
Table 2: CIT Group Inc M&A activity by geography (2014-YTD2018)
Table 3: CIT Group Inc corporate venturing volume and value trend (2014-YTD2018)
Table 4: CIT Group Inc corporate venturing by geography (2014-YTD2018)
Table 5: CIT Group Inc partnership volume and value trend (2014-YTD2018)
Table 6: CIT Group Inc partnership trend by key deal type (2014-YTD2018)
Table 7: CIT Group Inc capital raising volume and value trend (2014-YTD2018)
Table 8: CIT Group Inc capital raising by deal type (2014-YTD2018)
Table 9: CIT Group Inc divestments volume and value trend (2014-YTD2018)
Table 10: CIT Group Inc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: CIT Group Inc M&A volume and value trend (2014-YTD2018)
Figure 2: CIT Group Inc M&A activity by geography (2014-YTD2018)
Figure 3: CIT Group Inc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: CIT Group Inc corporate venturing by geography (2014-YTD2018)
Figure 5: CIT Group Inc partnership volume and value trend (2014-YTD2018)
Figure 6: CIT Group Inc partnership trend by key deal type (2014-YTD2018)
Figure 7: CIT Group Inc capital raising volume and value trend (2014-YTD2018)
Figure 8: CIT Group Inc capital raising by deal type (2014-YTD2018)
Figure 9: CIT Group Inc divestments volume and value trend (2014-YTD2018)
Figure 10: CIT Group Inc divestments by geography (2014-YTD2018)

★海外企業調査レポート[CIT Group Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also o …
  • Aeroport Anapa:企業の戦略・SWOT・財務情報
    Aeroport Anapa - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ventas, Inc.:戦略・SWOT・企業財務分析
    Ventas, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ventas, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • National Cheng Kung University:製薬・医療:M&Aディール及び事業提携情報
    Summary National Cheng Kung University (NCKU) is a research-led comprehensive university that offers educational and research services. The university’s services include graduate, undergraduate and postgraduate courses, research programs, master's programs, degree programs, doctoral courses, doctor' …
  • Color Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Color Genomics, Inc. (Color) provides physician ordered genetic testing service that helps to identify hereditary cancer risk. The company’s clinical grade test provides actionable results that enable consumers and their doctors to create personalized screening and healthcare plan. Color ana …
  • Vitol Holding BV:企業の戦略的SWOT分析
    Vitol Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Agfa HealthCare NV-医療機器分野:企業M&A・提携分析
    Summary Agfa HealthCare NV (Agfa HealthCare) a subsidiary of Agfa-Gevaert NV is a healthcare technology company that develops, produces and distributes analog and digital imaging systems and information technology solutions. The company operates through diagnostic imaging, enterprise imaging, integr …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • NTT Data Corporation:企業のM&A・事業提携・投資動向
    NTT Data Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NTT Data Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Allena Pharmaceuticals Inc (ALNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Allena Pharmaceuticals Inc (Allena) is a developer of oral enzyme therapeutics to treat patients with rare and severe metabolic disorders. The company develops ALLN-177, an oral recombinant oxalate degrading enzyme. It provides ALLN-177 which is developed for the chronic management of hypero …
  • Singapore Technologies Engineering Ltd (S63):企業の財務・戦略的SWOT分析
    Singapore Technologies Engineering Ltd (S63) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Union Investment Group:企業の戦略・SWOT・財務情報
    Union Investment Group - Strategy, SWOT and Corporate Finance Report Summary Union Investment Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Metlifecare Ltd (MET)-製薬・医療分野:企業M&A・提携分析
    Summary Metlifecare Ltd (Metlifecare) is a healthcare service provider that owns and manages retirement villages to older citizens in New Zealand. The center provides retirement villages provide services such as healthcare services, security, community and companionship, maintenance free living and …
  • Calypso Biotech SA-製薬・医療分野:企業M&A・提携分析
    Summary Calypso Biotech SA (Calypso) is a biopharmaceutical company that develops antibody therapies. The company’s pipeline products include CALY-0001 and CALY-0002. Its CALY-0001 therapeutic antibody is used in the treatment of Crohn’s disease; and CALY-0002 a humanized monoclonal antibody used in …
  • Smiths Group plc:企業の戦略・SWOT・財務情報
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Neuronetics Inc (STIM):医療機器:M&Aディール及び事業提携情報
    Summary Neuronetics Inc (Neuronetics) is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders. The company provides neurostar TMS therapy system used to treat patients with depressive disorder. Its neurostar TMS components comprise practice data ma …
  • ING Life Insurance Company Korea, Ltd.:企業の戦略・SWOT・財務情報
    ING Life Insurance Company Korea, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ING Life Insurance Company Korea, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • WorleyParsons Limited:企業の戦略・SWOT・財務分析
    WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report Summary WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SmithGroupJJR:企業の戦略・SWOT・財務情報
    SmithGroupJJR - Strategy, SWOT and Corporate Finance Report Summary SmithGroupJJR - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆